Granulocyte-colony stimulating factor impedes recovery from damage caused by cytotoxic agents through increased differentiation at the expense of self-renewal

Stem Cells

Volumn 18, Issue 2, 2000, Pages 120-127

  Van Os, Ronald ^a,b   Robinson, Simon ^a   Sheridan, Tara ^a   Mauch, Peter M ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

BCNU; Cobblestone area forming cell; Cytotoxic agents; G CSF; Hematopoiesis; Primitive stem cells

Indexed keywords

CARMUSTINE; CYCLOPHOSPHAMIDE; CYTOTOXIC AGENT; GRANULOCYTE COLONY STIMULATING FACTOR;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BONE MARROW CELL; CELL COUNT; CELL DAMAGE; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL RENEWAL; COLONY FORMING UNIT GM; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; HEMATOPOIESIS; LEUKOCYTE COUNT; MOUSE; NONHUMAN; STEM CELL;

ANIMALIA;

EID: 0034073650     PISSN: 10665099     EISSN: None     Source Type: Journal    
DOI: 10.1634/stemcells.18-2-120     Document Type: Article

References (32)

1. Botnick L, Hannon E, Hellman S. Multisystem stem cell failure after apparent recovery from alkylating agents. Cancer Res 1978;38:1942-1947.
2. Botnick L, Hannon E, Hellman S. A long lasting proliferative defect in the hematopoietic stem cell compartment following cytotoxic agents. Int J Radiat Oncol Biol Phys 1979;5:1621-1625.
3. Mauch P, Down J, Warhol M et al. Recipient preparation for bone marrow transplantation. I. Efficacy of total-body irradiation and busulfan. Transplantation 1988;46:205-209.
4. Abkowitz JL, Linenberger ML, Persik M et al. Behavior of feline hematopoietic stem cells years after bulsulfan exposure. Blood 1993;82:2096-2103.
5. Hornung R, Longo D. Hematopoietic stem cell depletion by restorative growth factor regimens during repeated high-dose cyclophosphamide therapy. Blood 1992;80:77-83.
6. Neben S, Hellman S, Montgomery M et al. Hematopoietic stem cell deficit of transplanted bone marrow previously exposed to cytotoxic agents. Exp Hematol 1993;21:438-443.
7. MacMillan J, Wolf N. Depletion of reserve in the hemopoietic system: II. Decline in CFU-S self renewal capacity following prolonged cell cycling. STEM CELLS 1982;2:45-58.
8. Mauch P, Rosenblatt M, Hellman S. Permanent loss in stem cell self renewal capacity following stress to the marrow. Blood 1988;72:1193-1196.
9. Mauch P, Hellman S. Loss of hematopoietic stem cell self-renewal after bone marrow transplantation. Blood 1989;74:872-875.
10. Dreger P, Kloss M, Petersen B et al. Autologous progenitor cell transplantation: prior exposure to stem cell-toxic drugs determines yield and engraftment of peripheral blood progenitor cell but not of bone marrow grafts. Blood 1995;86:3970-3978.
11. van der Wall E, Schaake-Koning CC, van Zandwijk N et al. The toxicity of radiotherapy following high-dose chemotherapy with peripheral blood stem cell support in high-risk breast cancer: a preliminary analysis. Eur J Cancer 1996;32A:1490-1497.
12. Freedman A, Neuberg D, Mauch P et al. Cyclophosphamide, doxorubicin, vincristine, prednisone dose intensification with granulocyte colony-stimulating factor markedly depletes stem cell reserve for autologous bone marrow transplantation. Blood 1997;90:4996-5001.
13. Brandt SJ, Peters WP, Atwater SK et al. Effect of recombinant human granulocyte-macrophage colony-stimulating factor on hematopoietic reconstitution after high-dose chemotherapy and autologous bone marrow transplantation. N Engl J Med 1988;318:869-876.
14. Sheridan WP, Morstyn G, Wolf M et al. Granulocyte colony-stimulating factor and neutrophil recovery after high-dose chemotherapy and autologous bone marrow transplantation. Lancet 1989;2:891-895.
15. Vose JM, Bierman PJ, Kessinger A et al. The use of recombinant human granulocyte-macrophage colony stimulating factor for the treatment of delayed engraftment following high dose therapy and autologous hematopoietic stem cell transplantation for lymphoid malignancies. Bone Marrow Transplant 1991;7:139-143.
16. Crawford J, Ozer H, Stoller R et al. Reduction by granulocyte colony-stimulating factor of fever and neutropenia induced by chemotherapy in patients with small-cell lung cancer. N Engl J Med 1991;325:164-170.
17. van Os R, Robinson S, Sheridan T et al. Granulocyte colony-stimulating factor enhances bone marrow stem cell damage caused by repeated administration of cytotoxic agents. Blood 1998;92:1950-1956.
18. Mauch P. Hematopoietic stem cell compartment: acute and late effects of radiation therapy and chemotherapy. Int J Radiat Oncol Biol Phys 1995;31:1319-1339.
19. Robinson S, van Os R, Sheridan T et al. Reduction of marrow hematopoietic progenitor and stem cell content is not sufficient for enhanced syngeneic engraftment. STEM CELLS 2000 (in press).
20. Ploemacher R. Cobblestone area forming cell (CAFC) assay. In: Freshney RI, Pragnell IB, Freshney MG, eds. Culture of Hemopoietic Cells. New York, NY: Wiley-Liss, Inc., 1994:1-21.
21. van Os R, Dawes D, Mislow J et al. Host conditioning with 5-Fluorouracil and kit-ligand to provide for long-term bone marrow engraftment. Blood 1997;89:2376-2383.
22. Fazekas de St.Groth S. The evaluation of limiting dilution assays. J Immunol Meth 1982;49:R11-R23.
23. Harrison DE. Competitive repopulation: a new assay for long-term stem cell functional capacity. Blood 1980;55:77-81.
24. Harrison D, Jordan C, Zhong R-K et al. Primitive hemopoietic stem cells: direct assay of most productive populations by competitive repopulation with simple binomial, correlation and covariance calculations. Exp Hematol 1993;21:206-219.
25. Botnick L, Hannon E, Viognuelle R et al. Differential effects of cytotoxic agents on hematopoietic progenitors. Cancer Res 1981;41:2338-2342.
26. Kay HEM. How many cell generations? Lancet 1965;2:418-419.
27. Hayflick L. The limited in vitro lifetime of human diploid cell strains. Exp Cell Res 1965;37:614-636.
28. Van Zant G, de Haan G, Rich IN. Alternatives to stem cell renewal from a developmental viewpoint. Exp Hematol 1997;25:187-192.
29. de Haan G, Nijhof W, Van Zant G. Mouse strain-dependent changes in frequency and proliferation of hematopoietic stem cells during aging: correlation between lifespan and cycling activity. Blood 1997;89:1543-1550.
30. Breems DA, Van Hennik PB, Kusadasi N et al. Individual stem cell quality in leukapheresis products is related to the number of mobilized stem cells. Blood 1996;87:5370-5378.
31. Neben S, Marcus K, Mauch P. Mobilization of hematopoietic stem and progenitor cell subpopulations from the marrow to the blood of mice following cyclophosphamide and/or granulocyte colony-stimulating factor. Blood 1993;81:1960-1967.
32. Watts M, Sullivan A, Leverett D et al. Back-up bone marrow is frequently ineffective in patients with poor peripheral blood stem cell mobilization. J Clin Oncol 1998;16:1554-1560.